Heme Oxygenase 1‐Targeted Hybrid Nanoparticle for Chemo‐ and Immuno‐Combination Therapy in Acute Myelogenous Leukemia
Abstract Acute myelogenous leukemia (AML) is a fatal blood cancer with high patient mortality. Daunorubicin and cytarabine are first‐line chemotherapy for AML, with bone marrow transplantation in most cases. Recently, cancer immunotherapy has been challenged in AML and leukemia‐niche myeloid cells a...
Main Authors: | Seok‐Beom Yong, Jaehyun Kim, Jee Young Chung, Sehee Ra, Seong Su kim, Yong‐Hee Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202000487 |
Similar Items
-
The role of inducible heme oxygenase-1 in modulating chemosensitivity of gastric adenocarcinoma.
Published: (2008) -
HEME OXYGENASE: ENZYME WITH FUNCTIONAL DIVERSITY
by: Shekhawat G. S., et al.
Published: (2011-03-01) -
Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases
by: Anne Grunenwald, et al.
Published: (2021-02-01) -
Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury
by: Maria G. Detsika, et al.
Published: (2021-01-01) -
Labile Heme and Heme Oxygenase‐1 Maintain Tumor‐Permissive Niche for Endometriosis‐Associated Ovarian Cancer
by: Canesin, G., et al.
Published: (2022)